Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
MTHRF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Is M3’s Share Buyback Progress Revealing a Shift in Capital Allocation Priorities for TSE:2413?
M3, Inc. recently announced the progress of its share repurchase program, having bought back 196,000 shares under a Board-approved plan to repurchase up to 20 million shares with a maximum budget of ¥20 billion. This buyback initiative ref…
Travelers from Singapore Can Now Access 24/7 Multilingual Online Doctor Consultations in Japan -- M3 Career's HOTEL de DOCTOR 24 Provides Peace of Mind During Unexpected Illness
TOKYO, Nov. 13, 2025 /PRNewswire/ -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining…
EverBridge Group and Cosmotec Forge Landmark Partnership
SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market.Jay Wang (Left) and Suguru Ominato…
MEDIROM Healthcare Technology‘s Subsidiary, MEDIROM MOTHER Labs, Raises an Aggregate Total of JPY260.3 Million in its Series A Financing Round
MEDIROM Healthcare Technologies Inc. Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization. Strategic Investors Further Validation of Technology and Growth Potential. Further Commerc…
M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
MEDIROM Healthcare Technologies Inc. TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating…
U.S. Stocks Open Lower After Strong November as Investors Await Fed Chair Jerome Powell
NEWSPLUS U.S. stocks opened lower on Friday, kicking off December with a slight decline, as investors await remarks from Federal Reserve Chair Jerome Powell. The Dow Jones Industrial Average was down less than 0. Continue reading
Nikkei Falls 0.2% in Likely Position Adjustment Before Powell’s Speech
Nikkei Stock Average edged 0.2% lower to close at 33431.51 in possible position adjustment ahead of Fed Chair Powell’s speech later today. Continue reading
New Partnership Adds Award-winning Clinical Research Leader, Dr. Donald Hurley, to Wake Research's National Network CHARLESTON, S.C., July 7, 2023 /PRNewswire/ -- M3 Wake Research, a leading fully integrated network of clinical research si…
M3 WAKE RESEARCH POISED TO EXPAND PHASE I TRIAL SERVICES
New Executive Role Will Lead Growth of Phase I Trial Operations Beyond RTP RALEIGH, N.C., March 7, 2023 /PRNewswire/ -- M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest prov…
M3-WAKE RESEARCH ACQUIRES MULTI-SPECIALTY RESEARCH ASSOCIATES OF LAKE CITY, FLORIDA
Addition of Well-Established Clinical Research Site Expands Operations into Florida, Offers Multi-specialty Expertise including Vaccines, Primary Care, and Women's Health RALEIGH, N.C., May 18, 2022 /PRNewswire/ -- M3 Wake Research, one of…
Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug
Shape Memory Medical Inc. announced today that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug in Japan. Cosmotec, which is a Group Company of M3 Inc https:…
Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug
Shape Memory Medical Inc. announced today that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug in Japan. Cosmotec, which is a Group Company of M3 Inc https:…
Wake Research Earns Recognition For Novavax COVID-19 Vaccine Trial, And As Top Clinical Service Provider Of 2021
Thousands of Patient Volunteers Enrolled for COVID Vaccine Trials Across Multiple Wake Research Locations RALEIGH, N.C., March 18, 2021 /PRNewswire/ -- Wake Research, an integrated national network of clinical investigative sites and one o…
Wake Research Earns Recognition For Novavax COVID-19 Vaccine Trial, And As Top Clinical Service Provider Of 2021
Thousands of Patient Volunteers Enrolled for COVID Vaccine Trials Across Multiple Wake Research Locations RALEIGH, N.C., March 18, 2021 /PRNewswire/ -- Wake Research, an integrated national network of clinical investigative sites and one o…
Research Marketing And Advertising (RMA) Expands Marketing Services To Clinical Research Industry Nationwide
New Website, RMAadagency.com, Provides Overview of Services and Quick Reference for Clinical Research Organizations in Need of Advertising Assistance RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ -- After more than nine years providing marketi…
Research Marketing And Advertising (RMA) Expands Marketing Services To Clinical Research Industry Nationwide
New Website, RMAadagency.com, Provides Overview of Services and Quick Reference for Clinical Research Organizations in Need of Advertising Assistance RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ -- After more than nine years providing marketi…
Demand for Online Doctors Creates $39 Billion Titan in Japan
(Bloomberg) -- Two decades ago, Itaru Tanimura ended a 12-year run at McKinsey & Co. to lead M3 Inc., an online provider of medical information and services backed by entertainment giant Sony Corp. What followed was a flurry of acquisition…
Demand for Online Doctors Creates $39 Billion Titan in Japan
(Bloomberg) -- Two decades ago, Itaru Tanimura ended a 12-year run at McKinsey & Co. to lead M3 Inc., an online provider of medical information and services backed by entertainment giant Sony Corp. What followed was a flurry of acquisition…
By Hideyuki Sano TOKYO, Aug 28 (Reuters) - Japanese shares fell on Friday by their most in almost a month on news Prime Minister Shinzo Abe will resign, bringing an abrupt end to his stable government and policy mix of aggressive monetary…
By Hideyuki Sano TOKYO, Aug 28 (Reuters) - Japanese shares fell on Friday by their most in almost a month on news Prime Minister Shinzo Abe will resign, bringing an abrupt end to his stable government and policy mix of aggressive monetary…
M3 Recognized On Forbes Global 2000, "The World's Largest Public Companies"
FORT WASHINGTON, Pa., Aug. 3, 2020 /PRNewswire/ -- M3, a global healthcare services firm specializing in market research, clinical research, media, and recruitment, is honored to be recognized by Forbes as one of the world's leading public…
M3 Recognized On Forbes Global 2000, "The World's Largest Public Companies"
FORT WASHINGTON, Pa., Aug. 3, 2020 /PRNewswire/ -- M3, a global healthcare services firm specializing in market research, clinical research, media, and recruitment, is honored to be recognized by Forbes as one of the world's leading public…
Japanese shares end lower as virus worries cloud sentiment
TOKYO, July 30 (Reuters) - Japanese shares reversed course to end lower on Thursday, as renewed concerns about rising cases of the novel coronavirus in Japan outweighed optimism around U.S. Federal Reserve’s decision and upbeat earnings re…
Japanese shares end lower as virus worries cloud sentiment
TOKYO, July 30 (Reuters) - Japanese shares reversed course to end lower on Thursday, as renewed concerns about rising cases of the novel coronavirus in Japan outweighed optimism around U.S. Federal Reserve’s decision and upbeat earnings re…